Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Search Results

Your search returned 1870 record(s).

Page 155 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:

  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1541 7.0 months Advanced hepatocellular carcinoma 5 Association Nationale des Hépato-Gastroentérologues des Hôpitaux Généraux France 7/2009
Treatment Details: Patients: This phase 3 study involved 272 patients with advanced liver cancer. Most of the patients (75%) were men. The median age was 70 years, ranging from 39 to 88. Treatment: Patie
1542 7.0 months Malignant gliomas 4 Chemotherapy
John Hopkins University School of Medicine United States 2/2008
Treatment Details: Patients: This phase II study involved 76 patients, 51 with glioblastoma multiforme and 19 with anaplastic astrocytoma. Treatment: Patients were treated with the chemotherapy drugs ci
1543 7.0 months Inoperavle advanced NSCLC 4 Chemotherapy
Louisiana Oncology Associates United States 9/2002
Treatment Details: Patients: This Phase II study involved 35 patients with unresectable (i.e. inoperable) advanced non-small-cell lung carcinoma. All patients had been previously treated with one chemotherapy
1544 7.0 months Malignant pleural mesothelioma 3 Chemotherapy
The Netherlands Cancer Institute Netherlands 2/2003
Treatment Details: Patients: This Phase II study involved 24 patients with malignant pleural mesothelioma; 19 men and 5 women. The median age was 63 years. Treatment: The treatment consisted of the drug
1545 7.0 months Recurrent GBM (second relapse) 3 Chemotherapy
Azienda Ospedale-Universita Italy 1/2002
Treatment Details: Patients: This Phase II study involved 42 patients with recurrent (second relapse) glioblastoma multiforme. All patients had received previous surgery, radiotherapy, and chemotherapy. Tr
1546 7.0 months Malignant Mesothelioma 5 Chemotherapy
Columbia University United States 7/2003
Treatment Details: Patients: This study involved 38 patients with malignant mesothelioma. Thirty-four had malignant pleural mesothelioma and four had malignant peritoneal mesothelioma. Treatment: The treat
1547 7.0 months Inoperable hepatocellular (liver) carcinoma 3 Radiation
Ghent University Hospital Belgium 7/2002
Treatment Details: Patients: This trial involved 20 patients with inoperable hepatocellular (liver) carcinoma. Patients were evenly divided into two groups – 10 patients in group A and 10 patients in group B.
1548 7.0 months Metastatic breast cancer 4 Chemotherapy
University Hospital of Helsinki Finland 5/2003
Treatment Details: Patients: This Phase II trial involved a total of 60 patients with metastatic breast cancer. Patients were divided into three groups (Groups 1-3). Group 1 had 26 patients, group 2 had 24
1549 6.9 months Unresectable or metastatic hepatocellular (liver) carcinoma 4 Chemotherapy
Dana-Farber Cancer Institute United States 6/2002
Treatment Details: Patients: This Phase II study involved 30 patients with measurable, unresectable, or metastatic hepatocellular (liver) carcinoma. Treatment: Treatment consisted of the chemotherapy drug g
1550 6.9 months Adnaced NSCLC 4 Chemotherapy
Istituto Nazionale dei Tumori Italy 3/2003
Treatment Details: Patients: This Phase III trial involved 698 patients with advanced non-small-cell lung cancer. All patients were age 70 or older. Patients were divided into three groups. Group 1 comprise
Page 155 of 187  | Previous Page  | Next Page